VCYT vs ACNB vs EXAS vs CZWI vs NTRA

For growth investors, Natera, Inc.

(NTRA) is the stronger pick with 35. 9% revenue growth year-over-year, versus -9. 4% for Citizens Community Bancorp, Inc. (CZWI). Citizens Community Bancorp, Inc. (CZWI) offers the better valuation at 14. 4x trailing P/E (11. 8x forward), making it the more compelling value choice. Analysts rate Veracyte, Inc. (VCYT) a "Buy" — based on 20 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Citizens Community Bancorp, Inc.

(CZWI) is the cheapest at 14. 4x versus Veracyte, Inc. at 49. 7x. On forward P/E, ACNB Corporation is actually cheaper at 9. 9x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: ACNB Corporation wins at 0. 90x versus Citizens Community Bancorp, Inc. 's 2. 32x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

Over the past 5 years, Natera, Inc.

(NTRA) delivered a total return of +115. 9%, compared to -8. 1% for Veracyte, Inc. (VCYT). Over 10 years, the gap is even starker: NTRA returned +1835% versus CZWI's +161. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Exact Sciences Corporation (EXAS) is the lower-risk stock at 0.

05β versus Veracyte, Inc. 's 1. 69β — meaning VCYT is approximately 3113% more volatile than EXAS relative to the S&P 500. On balance sheet safety, Veracyte, Inc. (VCYT) carries a lower debt/equity ratio of 3% versus 105% for Exact Sciences Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Natera, Inc.

(NTRA) is pulling ahead at 35. 9% versus -9. 4% for Citizens Community Bancorp, Inc. (CZWI). On earnings-per-share growth, the picture is similar: Veracyte, Inc. grew EPS 164. 5% year-over-year, compared to -3. 5% for ACNB Corporation. Over a 3-year CAGR, NTRA leads at 41. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

ACNB Corporation (ACNB) is the more profitable company, earning 21.

7% net margin versus -9. 0% for Natera, Inc. — meaning it keeps 21. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ACNB leads at 27. 3% versus -13. 4% for NTRA. At the gross margin level — before operating expenses — ACNB leads at 73. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, ACNB Corporation (ACNB) is the more undervalued stock at a PEG of 0. 90x versus Citizens Community Bancorp, Inc. 's 2. 32x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, ACNB Corporation (ACNB) trades at 9. 9x forward P/E versus 582. 8x for Exact Sciences Corporation — 572. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NTRA: 20. 8% to $265. 63.

In this comparison, ACNB (2.

6% yield), CZWI (1. 8% yield) pay a dividend. VCYT, EXAS, NTRA do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Exact Sciences Corporation (EXAS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

05), +1669% 10Y return). Veracyte, Inc. (VCYT) carries a higher beta of 1. 69 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (EXAS: +1669%, VCYT: +632. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (VCYT (Healthcare) and ACNB (Financial Services) and EXAS (Healthcare) and CZWI (Financial Services) and NTRA (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: VCYT is a small-cap high-growth stock; ACNB is a small-cap high-growth stock; EXAS is a mid-cap high-growth stock; CZWI is a small-cap deep-value stock; NTRA is a mid-cap high-growth stock. ACNB, CZWI pay a dividend while VCYT, EXAS, NTRA do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.